Mice lacking G-protein-coupled receptor 55 (GPR55) exhibit impaired contractile reserve and age-related systolic dysfunction, implying a role for this receptor in cardiac physiology/pathophysiology. To investigate the role of GPR55 in atherosclerosis-induced alterations in cardiac function, male and female, C57BL/6, ApoE-/-, GPR55-/- and ApoE-/-/GPR55-/- mice were fed a normal diet (ND) or high fat diet (HFD) for 12 weeks. Post-diet, indices of cardiac function were measured under anaesthesia via pressure-volume loop (PVL) analysis prior to harvesting blood and tissues for ex vivo analysis. Neither C57BL/6 nor GPR55-/- mice developed significant atherosclerotic plaques in the thoracic aorta, in response to HFD. ApoE-/- HFD mice demonstrated significant plaque deposition whereas ApoE-/-/GPR55-/- mice developed fewer plaques in response to HFD, suggesting GPR55 plays a detrimental role in atherogenesis. In contrast, while baseline systolic function (ejection fraction; EF and Emax) in ApoE-/- and GPR55-/- was similar to that in C57BL/6 mice, regardless of diet, high fat feeding in ApoE-/-/GPR55-/- mice caused a reduction systolic function, indicative of an important role for GPR55 in maintaining cardiac function in the hyperlipidaemic heart. Both ApoE-/- and ApoE-/-/GPR55-/- mice had similarly elevated LDL:HDL ratios, irrespective of diet, while GPR55-/- mice had similar LDL:HDL ratios to C57BL/6 mice that were unaffected by HFD. In conclusion, these results indicate that in the presence of high fat feeding, GPR55 has a complex role whereby it promotes atherosclerotic plaque development while maintaining systolic function. Neither of these role appears to be mediated by changes in plasma LDL:HDL ratios.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.